Track the Shanghai MicroPort MedBot (Group) Co., Ltd. - B share price and the full directors' dealings record of the company, a publicly traded company based in Hong Kong. Shares are quoted on the HK market, under the oversight of HKEX. Operating in the Health Care sector, Shanghai MicroPort MedBot (Group) Co., Ltd. - B has published 1 public disclosures. Market capitalisation: €21.4bn. The latest transaction was filed on 9 April 2026 (Purchase). Among the most active insiders: Liang Min. Every trade is free.
Analysts rate Shanghai MicroPort MedBot (Group) Co., Ltd. - B Strong Buy (bullish), based on 10 analysts. Average price target: HK$36.15.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
上海微创医疗机器人(集团)股份有限公司是一家专注于医疗技术和手术机器人开发的公司。该公司在香港证券交易所上市。